Abstract Body

Background: Peripheral neuropathy (PN) is a common and potentially debilitating neurologic complication of HIV infection. Systematic studies to identify the prevalence of and risk factors for PN in sub-Saharan Africa are lacking.

Methods: A sample of participants in the Rakai Community Cohort Study underwent detailed neurological evaluation including assessment of demographic characteristics, subjective PN symptoms, and a neurological examination by a trained medical officer. PN was defined as > 1 sign on examination (e.g. decreased pinprick or vibration in the fingers or toes, distal weakness, or reduced/ absent ankle reflexes) and > 1 subjective symptom (e.g. paresthesias, numbness, or pain in the hands or feet). PN risk factors were determined by comparing characteristics of participants with and without neuropathy using t-tests for continuous variables and chi-squared tests for categorical variables.

Results: 538 participants were enrolled: 200 HIV-positive (HIV+) antiretroviral (ARV) naïve participants with moderate immunosuppression (CD4 count 351-500), 107 HIV+ ARV-naïve participants with advanced immunosuppression (CD4 count <200), and 231 age and gender-matched HIV-negative (HIV-) participants. There were no demographic differences between HIV+ and HIV- participants, but HIV+ participants with advanced immunosuppression were younger (34 years vs. 37 years, p=0.002), more likely to be male (62% vs. 45%, p=0.004), and had lower body mass indexes (BMI) (20.7 vs. 23.0, p<0.001) than those with moderate immunosuppression. PN was more prevalent among HIV+ than HIV- participants (24% vs. 8%, p<0.001) and showed a trend toward statistical significance among HIV+ participants with advanced immunosuppression versus those with moderate immunosuppression (30% vs. 20%, p=0.05). In addition to HIV status and level of immunosuppression, older age (mean: 38 years vs. 35 years, p=0.03) was also a significant predictor of PN, but BMI (p=0.45), alcohol use (p=0.78), and prior isoniazid use (p=0.06) were not. PN severity was worse in HIV+ than HIV- participants as assessed by the Modified Total Neuropathy Scale (p=0.003).

Conclusions: PN is prevalent in rural Uganda and is more common in HIV+ individuals, with a trend toward increased prevalence in those with advanced disease. PN prevalence also increases with age. This highlights the need for early diagnosis and treatment of HIV to prevent this potentially debilitating complication and the necessity of close monitoring for PN as the HIV+ population ages.